Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer
Clinical trial NCT01875367 · COMPLETED
Trial details
- NCT number
- NCT01875367
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-18
- Primary completion
- 2016-11-30
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.